15-74893329-A-G

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_002435.3(MPI):​c.670+9A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.509 in 1,613,370 control chromosomes in the GnomAD database, including 218,919 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.45 ( 16246 hom., cov: 33)
Exomes 𝑓: 0.52 ( 202673 hom. )

Consequence

MPI
NM_002435.3 intron

Scores

10

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: -1.68
Variant links:
Genes affected
MPI (HGNC:7216): (mannose phosphate isomerase) Phosphomannose isomerase catalyzes the interconversion of fructose-6-phosphate and mannose-6-phosphate and plays a critical role in maintaining the supply of D-mannose derivatives, which are required for most glycosylation reactions. Mutations in the MPI gene were found in patients with carbohydrate-deficient glycoprotein syndrome, type Ib. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2014]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=6.217839E-5).
BP6
Variant 15-74893329-A-G is Benign according to our data. Variant chr15-74893329-A-G is described in ClinVar as [Benign]. Clinvar id is 94069.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr15-74893329-A-G is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.532 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
MPINM_002435.3 linkuse as main transcriptc.670+9A>G intron_variant ENST00000352410.9 NP_002426.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
MPIENST00000352410.9 linkuse as main transcriptc.670+9A>G intron_variant 1 NM_002435.3 ENSP00000318318 P1P34949-1

Frequencies

GnomAD3 genomes
AF:
0.448
AC:
68103
AN:
151966
Hom.:
16226
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.339
Gnomad AMI
AF:
0.434
Gnomad AMR
AF:
0.514
Gnomad ASJ
AF:
0.469
Gnomad EAS
AF:
0.230
Gnomad SAS
AF:
0.192
Gnomad FIN
AF:
0.429
Gnomad MID
AF:
0.411
Gnomad NFE
AF:
0.537
Gnomad OTH
AF:
0.442
GnomAD3 exomes
AF:
0.443
AC:
110737
AN:
249742
Hom.:
26725
AF XY:
0.433
AC XY:
58558
AN XY:
135140
show subpopulations
Gnomad AFR exome
AF:
0.332
Gnomad AMR exome
AF:
0.520
Gnomad ASJ exome
AF:
0.463
Gnomad EAS exome
AF:
0.220
Gnomad SAS exome
AF:
0.203
Gnomad FIN exome
AF:
0.432
Gnomad NFE exome
AF:
0.537
Gnomad OTH exome
AF:
0.473
GnomAD4 exome
AF:
0.515
AC:
752597
AN:
1461284
Hom.:
202673
Cov.:
40
AF XY:
0.505
AC XY:
366969
AN XY:
726964
show subpopulations
Gnomad4 AFR exome
AF:
0.331
Gnomad4 AMR exome
AF:
0.523
Gnomad4 ASJ exome
AF:
0.468
Gnomad4 EAS exome
AF:
0.245
Gnomad4 SAS exome
AF:
0.208
Gnomad4 FIN exome
AF:
0.438
Gnomad4 NFE exome
AF:
0.561
Gnomad4 OTH exome
AF:
0.483
GnomAD4 genome
AF:
0.448
AC:
68177
AN:
152086
Hom.:
16246
Cov.:
33
AF XY:
0.438
AC XY:
32554
AN XY:
74362
show subpopulations
Gnomad4 AFR
AF:
0.339
Gnomad4 AMR
AF:
0.514
Gnomad4 ASJ
AF:
0.469
Gnomad4 EAS
AF:
0.230
Gnomad4 SAS
AF:
0.192
Gnomad4 FIN
AF:
0.429
Gnomad4 NFE
AF:
0.537
Gnomad4 OTH
AF:
0.444
Alfa
AF:
0.467
Hom.:
7641
Bravo
AF:
0.458
TwinsUK
AF:
0.578
AC:
2145
ALSPAC
AF:
0.565
AC:
2178
ESP6500AA
AF:
0.325
AC:
1428
ESP6500EA
AF:
0.546
AC:
4690
ExAC
AF:
0.436
AC:
52990
Asia WGS
AF:
0.229
AC:
801
AN:
3478
EpiCase
AF:
0.524
EpiControl
AF:
0.523

ClinVar

Significance: Benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

MPI-congenital disorder of glycosylation Benign:5
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Benign, no assertion criteria providedclinical testingNatera, Inc.Sep 16, 2020- -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 10, 2021- -
Benign, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
not specified Benign:5
Benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Jul 10, 2012- -
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineMar 28, 2016Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: 44% of total chromosomes in ExAC -
Benign, criteria provided, single submitterclinical testingGeneDxDec 03, 2015This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
not provided Benign:1
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.53
T
BayesDel_noAF
Benign
-0.39
CADD
Benign
4.6
DANN
Benign
0.97
FATHMM_MKL
Benign
0.026
N
LIST_S2
Benign
0.20
T
MetaRNN
Benign
0.000062
T
MutationTaster
Benign
1.0
P;P;P;P;P;P;P;P;P
PROVEAN
Benign
-1.1
N
Sift
Benign
0.51
T
Sift4G
Benign
0.43
T
Vest4
0.030
GERP RS
-0.38

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.070
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs7495739; hg19: chr15-75185670; COSMIC: COSV60396694; COSMIC: COSV60396694; API